Cancer Center News and Updates

Children’s Hospital of Philadelphia Receives Multi-Million Dollar Gift from Holveck Family to Support Groundbreaking Osteosarcoma Research

Published on Nov 16, 2023

Children’s Hospital of Philadelphia (CHOP) has received a $6.4 million gift from the family of Connor Boyle, a Central Bucks East High School graduate who died at age 18 from osteosarcoma. This three-year gift, named The Connor Initiative: Precision Therapeutics for Osteosarcoma & Rare Cancers, will support cutting-edge research in osteosarcoma and other rare cancers.

Dr. Yael Mossé and her team of global experts selected as finalists for the next Cancer Grand Challenges Awards

Published on Sep 05, 2023

Dr. Mossé and her team, named KOODAC, will now compete for a chance to receive up to $25 million to tackle some of cancer's toughest challenges.

CHOP Establishes Kelly and Chad Punchard Endowed Chair in Translational Sarcoma Research

Published on Aug 18, 2023

Children’s Hospital of Philadelphia (CHOP) has announced the establishment of the Punchard Family Endowed Chair in Translational Sarcoma Research. Patrick J. Grohar, MD, PhD, an attending physician with the Cancer Center and the Director of Translational Research with the Center for Childhood Cancer Research at CHOP, has been named the inaugural chair holder.

CHOP and Penn Researchers Find Behavioral Economics Strategies Can Help Patients Quit Smoking After a Cancer Diagnosis

Published on Jul 19, 2023

“Nudges” from electronic health records could improve the implementation of tobacco use treatment almost three-fold over standard care.

CHOP Treats 500th CAR T Patient

Published on Jul 17, 2023

CHOP has treated its 500th patient with CAR T-cell immunotherapy, a “living drug” that harnesses the power of a patient’s own immune system to fight cancer.

Children’s Hospital of Philadelphia Receives $1 Million Grant from Pediatric Cancer Foundation

Published on Jun 28, 2023

Children’s Hospital of Philadelphia (CHOP) announced it has received $1 million from Pediatric Cancer Foundation, an organization that has been raising funds for research since 1970 to support doctors and hospitals in an effort to eradicate childhood cancer. The grant will help to fund a planned first-in-human phase 1 clinical trial led by Sarah K. Tasian, MD, which will use a new immunotherapy to target the FLT3 receptor protein in high-risk pediatric leukemias.

CHOP Researchers Identify Potential Target in Myeloid Malignancies

Published on Jun 15, 2023

CHOP researchers have identified a molecule that plays a role in post-translational modification and activation in myeloid cancers, making it a potential therapeutic target.

Stephanie Fooks-Parker Presented with the Alex’s Lemonade Stand Foundation 2023 Pitcher of Hope Award

Published on Jun 14, 2023

This award honors a CHOP employee who has gone above and beyond to make an impact on the lives of children treated in the Division of Oncology.

First-of-its-Kind Open-Analysis Platform for Pediatric Brain Tumors Provides Robust Data Resource for Childhood Cancer Research

Published on May 31, 2023

Collaboration among CHOP, Alex’s Lemonade Stand Foundation, the Pacific Pediatric Neuro-Oncology Consortium, and Children’s Brain Tumor Network paves the way for new collaborative models to accelerate discoveries.

New Computational Tool Identifies Novel Targets for Cancer Immunotherapy

Published on May 17, 2023

CHOP and UCLA researchers have created a tool that can discover tumor antigens derived from alternative RNA splicing, expanding the pool of cancer immunotherapy targets.

Search